Last reviewed: June 27, 2026
Last updated: June 27, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide starts working on appetite and blood sugar within days, but visible weight loss typically emerges after 2–3 weeks of consistent dosing. The medication's mechanism—slowing gastric emptying and signaling fullness to your brain—creates the foundation for weight reduction over time rather than immediate drops on the scale.
How Semaglutide Actually Works in Your Body
Semaglutide activates GLP-1 receptors in your pancreas, brain, and digestive tract. This activation takes time because the medication must build up in your system and your body's receptors must fully respond. During the first week, you may notice reduced hunger or less interest in foods you normally crave, but your metabolism hasn't yet shifted enough to shed visible pounds.
The drug slows how fast your stomach empties food into your intestines, which extends feelings of fullness and reduces overall calorie intake naturally. This process happens gradually—your body doesn't flip a switch on day one. Many patients report that appetite suppression feels strongest around days 3–5, yet the scale doesn't reflect weight loss until day 10 or later.
Why the Scale Doesn't Move Immediately
Weight loss requires a calorie deficit over multiple days, not hours. One week of reduced eating may only create a 3,000–5,000 calorie deficit, which translates to less than two pounds of actual fat loss. The body also holds water, and inflammation from digestive changes can mask fat loss on the scale during the first 7–10 days.
Starting doses of semaglutide are intentionally low—typically 0.25 mg—to let your body adapt and minimize nausea. At this dose, appetite suppression is mild compared to higher maintenance doses. PlexusDx compounded semaglutide injections start at $149 per month across all doses, meaning your dose may need to go up as your body adjusts, but your price won't.
What You Should Expect in Weeks Two Through Four
Most patients report noticeable weight loss beginning in week 2 or 3 once the medication has accumulated in their system and they've sustained a consistent calorie deficit. By week 4, many experience 2–5 pounds of loss, depending on starting weight, diet quality, and adherence. This steady pace—roughly 1–2 pounds per week—aligns with healthy, sustainable weight reduction that your body can maintain long-term.
During this period, appetite suppression deepens, food portions naturally shrink, and food noise—constant thoughts about eating—often quiets dramatically. Patients frequently report that they forget to eat or lose interest in previously favorite foods. This psychological shift is as important as the physical weight loss for creating lasting behavior change.
Genetic Factors That Influence Your Personal Response
Your genetic makeup affects how strongly you respond to GLP-1 therapy. Variations in the GLP1R gene (like rs6923761) and the GIPR gene (rs1800437) influence how efficiently your GLP-1 receptors bind and signal. Some patients have genetic variants that amplify appetite suppression, while others may require slightly higher doses to feel the same effect.
PlexusDx offers the Precision Peptide Genetic Test ($99 add-on after your first month) to map 14 metabolic pathways and 150+ genetic insights tied to peptide response. This test identifies variants in GLP1R, GIPR, FTO, and MC4R—all relevant to how your body processes semaglutide. Patients who understand their genetic predispositions can set more accurate expectations and adjust their treatment plan with their provider for optimal results.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is it normal to lose zero pounds in the first week on semaglutide?
Yes, completely normal. One week is too short for meaningful fat loss because your body needs sustained calorie reduction and time for the medication to reach therapeutic levels. Most patients see their first weight drop between days 8–14 of treatment.
Should I increase my semaglutide dose if I don't lose weight in week one?
No. Starting low (0.25 mg) allows your body to tolerate the medication and adapt. Doses typically increase every 4 weeks as directed by your provider. Premature increases raise nausea and side effects without speeding weight loss.
How much weight loss is realistic in the first month?
Most patients lose 2–5 pounds in month one, with some variation based on starting weight and diet. Heavier individuals may see faster initial loss. This pace—roughly 1–2 pounds per week after week two—is considered healthy and sustainable.
Can the Precision Peptide Genetic Test predict how fast I'll lose weight?
The Precision Peptide Genetic Test identifies variants in GLP1R, GIPR, FTO, and MC4R that influence appetite suppression and metabolic response. Patients with certain variants may experience stronger early appetite reduction or may need slightly higher doses, helping your provider personalize your treatment for better outcomes.
Does PlexusDx offer semaglutide at different price points for different doses?
No. PlexusDx compounded semaglutide injection starts at $149 per month flat, regardless of dose. Your dose may need to go up as your body adjusts, but your price won't. All medications come from licensed 503A compounding pharmacies and are available nationwide without insurance.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Is Runny Nose a Side Effect of Ozempic?
How Long to See Weight Loss on Wegovy: Your Comprehensive Guide